There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alcon (ALC – Research Report) and Iradimed (IRMD – Research Report) with bullish sentiments.
Alcon (ALC)
Stifel Nicolaus analyst Thomas Stephan maintained a Buy rating on Alcon today and set a price target of $95.00. The company’s shares closed last Friday at $79.55.
According to TipRanks.com, Stephan is a 4-star analyst with an average return of
Alcon has an analyst consensus of Moderate Buy, with a price target consensus of $92.18, representing a 16.1% upside. In a report issued on April 10, Goldman Sachs also initiated coverage with a Buy rating on the stock with a $100.00 price target.
See the top stocks recommended by analysts >>
Iradimed (IRMD)
Roth MKM analyst Jason Wittes initiated coverage with a Buy rating on Iradimed today and set a price target of $65.00. The company’s shares closed last Friday at $41.00.
According to TipRanks.com, Wittes is a 4-star analyst with an average return of
Iradimed has an analyst consensus of Strong Buy, with a price target consensus of $62.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ALC:
